Fig. 3From: Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccineHeterologous HIV-prime SIV-boost regimen induced broadly reactive Env-specific antibody responses. Serum samples were taken 10 days after the boost and analyzed for antibody binding to lyzed pseudoviruses carrying a HIV-1 clade B (HIV B), b SIVmac239 and c HIV-1 clade C (HIV C) Env, by ELISA. Horizontal lines indicate the geometric mean and significant differences are marked by asterisks with *(p ≤ 0.05), **(p ≤ 0.01) and ***(p ≤ 0.001)Back to article page